Tenaya Therapeutics Inc (TNYA)
4.56
+0.02
(+0.44%)
USD |
NASDAQ |
Apr 30, 16:00
4.45
-0.11
(-2.41%)
After-Hours: 20:00
Tenaya Therapeutics Accounts Payable (Quarterly): 5.63M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.63M |
| September 30, 2023 | 5.902M |
| June 30, 2023 | 8.484M |
| March 31, 2023 | 7.43M |
| December 31, 2022 | 9.578M |
| September 30, 2022 | 5.312M |
| June 30, 2022 | 5.347M |
| Date | Value |
|---|---|
| March 31, 2022 | 8.888M |
| December 31, 2021 | 10.72M |
| September 30, 2021 | 6.171M |
| June 30, 2021 | 5.02M |
| March 31, 2021 | 2.092M |
| December 31, 2020 | 1.017M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.017M
Minimum
Dec 2020
10.72M
Maximum
Dec 2021
6.276M
Average
5.902M
Median
Sep 2023
Accounts Payable (Quarterly) Benchmarks
| Adverum Biotechnologies Inc | 1.921M |
| Solid Biosciences Inc | 2.032M |
| Dyne Therapeutics Inc | 22.94M |
| Sana Biotechnology Inc | 4.108M |
| Prime Medicine Inc | 19.54M |